Literature DB >> 16076076

Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.

E Zimmermann1, E B Souto, R H Müller.   

Abstract

A solid lipid nanoparticle (SLN) formulation, based on the lipid Imwitor 900, was developed for the incorporation of the poorly water soluble drug RMEZ98. Physicochemical investigations were undertaken to examine the structure and physical stability of the selected lipid as colloidal dispersion in comparison to the bulk material. Using differential scanning calorimetry (DSC) and proton nuclear magnetic resonance (1H NMR) it could be assessed the influence of the incorporated drug on the structure of the lipid matrix. Investigation of mixtures of Imwitor 900 and RMEZ98 showed an increasing effect on the melting/recrystallization behaviour with increasing drug content (5-30%). DSC and 1H NMR results revealed the formation of a crystalline matrix of SLN when prepared by high pressure homogenization excluding, therefore, the phenomenon of supercooled melt. After preparation of RMEZ98-loaded SLN, the drug remained inside the lipid matrix; however, it exhibited only a small effect on the recrystallization behaviour of Imwitor 900 at the lowest payload required for a therapeutic effect (4% m/m with regard to the lipid matrix). Furthermore, the incorporation of RMEZ98 revealed no distinct influence on the particle size distribution. Imwitor 900 proved to be a suitable lipid for the drug RMEZ98, i.e. possessing a sufficient loading capacity and simultaneously physical stability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076076

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  8 in total

Review 1.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

Review 2.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

3.  Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid Nanocapsules.

Authors:  Huafeng Zhou; Yang Yue; Guanlan Liu; Yan Li; Jing Zhang; Zemin Yan; Mingxing Duan
Journal:  Nanoscale Res Lett       Date:  2010-07-20       Impact factor: 4.703

4.  Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.

Authors:  Maria João Gomes; Susana Martins; Domingos Ferreira; Marcela A Segundo; Salette Reis
Journal:  Int J Nanomedicine       Date:  2014-03-07

5.  Evaluation of Nanostructured Lipid Carriers Produced with Interesterified Buriti Oil.

Authors:  Lívia Viana de Castro Reis; Karina Magna Leão; Paula Speranza; Ana Paula Badan Ribeiro; Gabriela Alves Macedo; Juliana Alves Macedo
Journal:  Food Technol Biotechnol       Date:  2020-09       Impact factor: 3.918

Review 6.  Nanostructured Lipid Carriers-Hydrogels System for Drug Delivery: Nanohybrid Technology Perspective.

Authors:  Sharifah Nurfadhlin Afifah Syed Azhar; Siti Efliza Ashari; Norhazlin Zainuddin; Masriana Hassan
Journal:  Molecules       Date:  2022-01-04       Impact factor: 4.411

7.  Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active.

Authors:  Georgia I Sakellari; Ioanna Zafeiri; Hannah Batchelor; Fotis Spyropoulos
Journal:  Food Hydrocoll Health       Date:  2021

8.  Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation.

Authors:  Giuliana Mancini; Lídia M D Gonçalves; Joana Marto; Filomena A Carvalho; Sandra Simões; Helena Margarida Ribeiro; António J Almeida
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.